Novartis to Cut 1,960 U.S. Jobs

Category: Health

Publish Date: 01-13-2012 03:53 PM -0800

Novartis said it will cut 1,960 jobs as it restructures its U.S. business, reflecting the patent loss of heart drug Diovan in the U.S. and the recent failure to turn high-blood pressure medicine Rasilez into a blockbuster.

Continue to Original Story >